Genetic association between COPD and polymorphisms in TNF, ADRB2 and EPHX1

被引:73
作者
Brogger, J
Steen, VM
Eiken, HG
Gulsvik, A
Bakke, P
机构
[1] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway
[2] Inst Med, Dept Thorac Med, Bergen, Norway
[3] Univ Bergen, Dept Clin Med, Sect Med Genet & Mol Med, Bergen, Norway
关键词
beta(2)-adrenergic receptor; case-control study; chronic obstructive pulmonary disease; genetics; microsomal epoxide hydroxylase; tumour necrosis factor-alpha;
D O I
10.1183/09031936.06.00057005
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
There is evidence of a hereditary component in chronic obstructive pulmonary disease (COPD). A number of genetic association studies have been performed to find susceptibility genes of COPD. The current authors performed a case-control, genetic-association study and a meta-analysis of 16 studies, involving seven polymorphisms in three well-studied genes: microsomal epoxide hydroxylase (EPHX1); tumour necrosis factor; and beta(2)-adrenoreceptor. A total of 492 Caucasian smokers and former smokers were recruited from hospital databases and population cohort studies. In the present study, a protective effect of the EPHX1 Tyr113His polymorphism was found (homozygous odds ratio (OR) 0.5). In the meta-analysis, homozygotes for this single nucleotide polymorphism (SNP) also had a pooled OR of 0.5. The same effect has been found in several lung cancer studies. Effects for other candidate SNPs were weak or statistically insignificant, and probable genotyping error was common. In conclusion, the present data and meta-analysis support a role for microsomal epoxide hydroxylase in the aetiology of chronic obstructive pulmonary disease.
引用
收藏
页码:682 / 688
页数:7
相关论文
共 42 条
[1]   Is there a future for TNF promoter polymorphisms? [J].
Bayley, JP ;
Ottenhoff, THM ;
Verweij, CL .
GENES AND IMMUNITY, 2004, 5 (05) :315-329
[2]  
Budhi A, 2003, INT J MOL MED, V11, P321
[3]  
BURROWS B, 1977, AM REV RESPIR DIS, V115, P195
[4]   Incidence of asthma and respiratory symptoms by sex, age and smoking in a community study [J].
Eagan, TML ;
Bakke, PS ;
Eide, GE ;
Gulsvik, A .
EUROPEAN RESPIRATORY JOURNAL, 2002, 19 (04) :599-605
[5]   Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema [J].
Ferrarotti, I ;
Zorzetto, M ;
Beccaria, M ;
Gilè, LS ;
Porta, R ;
Ambrosino, N ;
Pignatti, PF ;
Cerveri, I ;
Pozzi, E ;
Luisetti, M .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (03) :444-449
[6]   Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk [J].
Gsur, A ;
Zidek, T ;
Schnattinger, K ;
Feik, E ;
Haidinger, G ;
Hollaus, P ;
Mohn-Staudner, A ;
Armbruster, C ;
Madersbacher, S ;
Schatzl, G ;
Trieb, K ;
Vutuc, C ;
Micksche, M .
BRITISH JOURNAL OF CANCER, 2003, 89 (04) :702-706
[7]   Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations [J].
Hersh, CP ;
DeMeo, DL ;
Lange, C ;
Litonjua, AA ;
Reilly, JJ ;
Kwiatkowski, D ;
Laird, N ;
Sylvia, JS ;
Sparrow, D ;
Speizer, FE ;
Weiss, ST ;
Silverman, EK .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2005, 33 (01) :71-78
[8]   Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease [J].
Higham, MA ;
Pride, NB ;
Alikhan, A ;
Morrell, NW .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (02) :281-284
[9]   Polymorphism of the β2-adrenoceptor in COPD in Chinese subjects [J].
Ho, LI ;
Harn, HJ ;
Chen, CJ ;
Tsai, NM .
CHEST, 2001, 120 (05) :1493-1499
[10]   Detection of genotyping errors by Hardy-Weinberg equilibrium testing [J].
Hosking, L ;
Lumsden, S ;
Lewis, K ;
Yeo, A ;
McCarthy, L ;
Bansal, A ;
Riley, J ;
Purvis, I ;
Xu, CF .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (05) :395-399